NVCT   $7.59  12.28% Market Closed After Close 7.7 1.45%

Nuvectis Pharma Inc

EMA (20): 2024-10-11 the price crossed up the moving average line and demonstrates a strong upside trend.

EMA (50): 2024-10-14 the price crossed up the moving average line and formed a short-term upside trend.

EMA (100): 2024-10-17 the price crossed up the moving average line and formed a short-term upside trend.

RSI: RSI indicator is in the lower part of the neutral territory and it heading north. These factors indicate that the upside trend is forming Last signal: exit from the overbought zone.

MACD: Oscillator MACD is in the positive territory it's higher than the signal line and grows. These factors mean that positive mood prevails. Last signal: up-crossing the middle level.

Stochastic: The stochastic indicator is in overbought territory and it grows. These factors indicate that the upside potential still holds even though the market is overbought. Last signal: entrance to the overbought zone.

Trend Type linear down
Power medium strength
Trend Pattern
EMA (20) Signals bullish reversal
EMA (20) Yield 16.68%
EMA (20) date of signal Oct. 11, 2024, 3 a.m.
EMA (50) Signals bullish reversal
EMA (50) Yield 15.41%
EMA (50) date of signal Oct. 14, 2024, 3 a.m.
EMA (100) Signals bullish reversal
EMA (100) Yield 10.12%
EMA (100) date of signal Oct. 17, 2024, 3 a.m.
RSI Signals bullish
RSI (14) Yield 16.68%
RSI (14) date of signal Oct. 11, 2024, 3 a.m.
MACD Signals bullish
MACD Yield 10.12%
MACD date of signal Oct. 17, 2024, 3 a.m.
Stochastic Signals bullish
Stochastic Yield 14.70%
Stochastic date of signal Oct. 15, 2024, 3 a.m.
Updated Oct. 18, 2024, 11:03 p.m.